reference/13190845

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/13190845

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	34
issn	1468-1293 1464-2662
issueIdentifier	1
pageRange	27-34
publicationName	HIV Medicine
startingPage	27
bibliographicCitation	Katlama C, Clotet B, Plettenberg A, Jost J, Arasteh K, Bernasconi E, Jeantils V, Cutrell A, Stone C, Purdon S; CNA3002 European Study Team. Intensification of stable background therapy with abacavir in antiretroviral therapy experienced patients: 48-week data from a randomized, double-blind trial. HIV Med. 2001 Jan;2(1):27–34. doi: 10.1046/j.1468-1293.2001.00043.x. PMID: 11737373.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_61835a9ab139a89eb09056ed09bd2624 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8f99ad25cf20b33c260ea084f94d4eeb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_319fc4e2de36bd68677880a1826e6940 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_482f835b934346ee2375d845db36c975 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89ab55b3814db9c1db84ecc5c98a9588 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f753595916f686fb7097e8d75d6af6fa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_62d69593e6d8a2a1233775f43724ebb6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_30585713d4ffad292cff3d2bbe1a530e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ccd91c49b7d47ae3053f3d3b2881be3e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1d0dec8bf968465e862d2a0658563a64
date	200101
identifier	https://pubmed.ncbi.nlm.nih.gov/11737373 https://doi.org/10.1046/j.1468-1293.2001.00043.x
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/26808 https://portal.issn.org/resource/ISSN/1464-2662 https://portal.issn.org/resource/ISSN/1468-1293
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Intensification of stable background therapy with abacavir in antiretroviral therapy experienced patients: 48‐week data from a randomized, double‐blind trial
discusses	http://id.nlm.nih.gov/mesh/M0028839 http://id.nlm.nih.gov/mesh/M0028255 http://id.nlm.nih.gov/mesh/M0277557 http://id.nlm.nih.gov/mesh/M0019224 http://id.nlm.nih.gov/mesh/M0023387
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D018894Q000627 http://id.nlm.nih.gov/mesh/D019380Q000008 http://id.nlm.nih.gov/mesh/D015658Q000188 http://id.nlm.nih.gov/mesh/D012367Q000097 http://id.nlm.nih.gov/mesh/D015224Q000627 http://id.nlm.nih.gov/mesh/D015497
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D018894Q000008 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D019562 http://id.nlm.nih.gov/mesh/D015496Q000378 http://id.nlm.nih.gov/mesh/D004357 http://id.nlm.nih.gov/mesh/D005060 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D023241 http://id.nlm.nih.gov/mesh/D015224Q000008 http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.7.7.49 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441300 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23480 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60825 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128575040 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128324017

Showing number of triples: 1 to 61 of 61.